Encision Inc. Overview
Pro stress-test →Encision Inc. designs and markets a portfolio of high-performance surgical instrumentation that delivers advances in patient safety with AEM technology, surgical performance, and value to hospitals across a broad range of minimally invasive surgical procedures. The company has established and developed AEM (Active Electrode Monitoring) technology and surgical instruments which provide surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures while preventing stray electrosurgical energy that can cause complications and even death.
Strategic Profile
Pro stress-test →The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. The AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company sells its products through a network of direct and independent sales representatives.
Competitive Landscape
Pro stress-test →Encision competes in the minimally invasive surgical instruments market against larger established players like Mediflex and broader surgical device manufacturers (Ethicon, Stryker, Karl Storz). Its AEM technology provides a differentiation point, but limited scale, capital, and market reach severely constrain its competitive position relative to well-resourced incumbents who dominate hospital relationships and reimbursement pathways.
Industry Context
Encision Inc. operates in Surgical Instruments.
Key facts
Founded: 1991 · Headquarters: Boulder, Colorado, US · Employees: 51-200 · Revenue: $6.3M (trailing 12-month as of September 2025) · Market cap: $5M (June 2026)